|
1
|
Prasad J, Shrivastava A, Khanna AK, Bhatia
G, Awasthi SK and Narendera T: Antidyslipidemic and antioxidant
activity of the constituents isolated from the leaves of
Calophyllum inophyllum. Phytomedicine. 19:1245–1249. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tsai SC, Liang YH, Chiang JH, Liu FC, Lin
WH, Chang SJ, Lin WY, Wu CH and Weng JR: Anti-inflammatory effects
of Calophyllum inophyllum L. in RAW264.7 cells. Oncol Rep.
28:1096–1102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Spino C, Dodier M and Sotheeswaran S:
Anti-HIV coumarins from calophyllum seed oil. Bioorg Med Chem Lett.
8:3475–3478. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Venugopala KN, Rashmi V and Odhav B:
Review on natural coumarin lead compounds for their pharmacological
activity. Biomed Res Int. 2013:9632482013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Luo KW, Sun JG, Chan JY, Yang L, Wu SH,
Fung KP and Liu FY: Anticancer effects of imperatorin isolated from
Angelica dahurica: Induction of apoptosis in HepG2 cells through
both death-receptor and mitochondria-mediated pathways.
Chemotherapy. 57:449–459. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yun ES, Park SS, Shin HC, Choi YH, Kim WJ
and Moon SK: p38 MAPK activation is required for esculetin-induced
inhibition of vascular smooth muscle cells proliferation. Toxicol
In Vitro. 25:1335–1342. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang D, Gu T, Wang T, Tang Q and Ma C:
Effects of osthole on migration and invasion in breast cancer
cells. Biosci Biotechnol Biochem. 74:1430–1434. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Itoigawa M, Ito C, Tan HT, Kuchide M,
Tokuda H, Nishino H and Furukawa H: Cancer chemopreventive agents,
4-phenylcoumarins from Calophyllum inophyllum. Cancer Lett.
169:15–19. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cooper GM: The Development and Causes of
Cancer. The Cell: A Molecular Approach. 2nd. Sinauer Associates;
Sunderland, MA: 2000
|
|
10
|
World Health Organization, . Cancer
worldwide = World Cancer Report 2014. Stewart BW and Wild CP: IARC
Nonserial Publication; pp. 16–81. 2014
|
|
11
|
Parkinn DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
World Health Organization, . GLOBOCAN
2012: Estimated Cancer Incidence, Mortality and Prevalence
Worldwide in 2012. Cancer fact sheets: Lung. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspxDec
27–2013
|
|
13
|
Dikshit R, Gupta PC, Ramasundarahettige C,
Gajalakshmi V, Aleksandrowicz L, Badwe R, Kumar R, Roy S, Suraweera
W, Bray F, et al: Cancer mortality in India: A nationally
representative survey. Lancet. 379:1807–1816. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Earp HS, Dawson TL, Li X and Yu H:
Heterodimerization and functional interaction between EGF receptor
family members: A new signaling paradigm with implications for
breast cancer research. Breast Cancer Res Treat. 35:115–132. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yeh CH, Yang ST and Chen CH: Calvatia
lilacina protein extract induces apoptosis through endoplasmic
reticulum stress in human colon carcinoma cells. Process Biochem.
46:1599–1606. 2011. View Article : Google Scholar
|
|
16
|
Chen CH, Lin WC, Kuo CN and Lu FJ: Role of
redox signaling regulation in propyl gallate-induced apoptosis of
human leukemia cells. Food Chem Toxicol. 49:494–501. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang JT, Li ZL, Wu JY, Lu FJ and Chen CH:
An oxidative stress mechanism of shikonin in human glioma cells.
PLoS One. 9:e941802014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen CY, Li ZL, Chung KT, Lu FJ and Chen
CH: Liriodenine enhances the apoptosis effect of valproic acid in
human colon cancer cells through oxidative stress upregulation and
Akt inhibition. Process Biochem. 49:1990–2000. 2014. View Article : Google Scholar
|
|
19
|
Chen TR, Dorotinsky CS, McGuire LJ, Macy
ML and Hay RJ: DLD-1 and HCT-15 cell lines derived separately from
colorectal carcinomas have totally different chromosome changes but
the same genetic origin. Cancer Genet Cytogenet. 81:103–108. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gartel AL: Mechanisms of apoptosis induced
by anticancer compounds in melanoma cells. Curr Top Med Chem.
12:50–52. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Z, Xiao Z, Gu WZ, Xue J, Bui MH,
Kovar P, Li G, Wang G, Tao ZF, Tong Y, et al: Selective Chk1
inhibitors differentially sensitize p53-deficient cancer cells to
cancer therapeutics. Int J Cancer. 119:2784–2794. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hirose Y, Berger MS and Pieper RO:
Abrogation of the Chk1-mediated G(2) checkpoint pathway potentiates
temozolomide-induced toxicity in a p53-independent manner in human
glioblastoma cells. Cancer Res. 61:5843–5849. 2001.PubMed/NCBI
|
|
23
|
Kawabe T: G2 checkpoint abrogators as
anticancer drugs. Mol Cancer Ther. 3:513–519. 2004.PubMed/NCBI
|
|
24
|
Karunagaran D, Rashmi R and Kumar TR:
Induction of apoptosis by curcumin and its implications for cancer
therapy. Curr Cancer Drug Targets. 5:117–129. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang WZ, Cheng J, Luo J and Zhuang SM:
Abrogation of G2/M arrest sensitizes curcumin-resistant hepatoma
cells to apoptosis. FEBS Lett. 582:2689–2695. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sridhar SS, Seymour L and Shepherd FA:
Inhibitors of epidermal-growth-factor receptors: A review of
clinical research with a focus on non-small-cell lung cancer.
Lancet Oncol. 4:397–406. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okita R, Wolf D, Yasuda K, Maeda A, Yukawa
T, Saisho S, Shimizu K, Yamaguchi Y, Oka M, Nakayama E, et al:
Contrasting effects of the cytotoxic anticancer drug gemcitabine
and the EGFR tyrosine kinase inhibitor gefitinib on NK
cell-mediated cytotoxicity via regulation of NKG2D ligand in
non-small-cell lung cancer cells. PLoS One. 10:e01398092015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cui F, Wang W, Wu D, He X, Wu J and Wang
M: Overexpression of cathepsin L is associated with gefitinib
resistance in non-small cell lung cancer. Clin Transl Oncol.
18:722–727. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li N, Li H, Su F, Li J, Ma X and Gong P:
Relationship between epidermal growth factor receptor (EGFR)
mutation and serum cyclooxygenase-2 level, and the synergistic
effect of celecoxib and gefitinib on EGFR expression in non-small
cell lung cancer cells. Int J Clin Exp Pathol. 8:9010–9020.
2015.PubMed/NCBI
|
